AIM

#5038
AIM ImmunoTech Inc.
0.5800 USD
+7.57%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
0.5701
0.5840
Range Annuel
0.5060
20.3500
Changement quotidien
+7.57%
Changement Mensuel
-22.67%
Evolution sur 6 mois
-77.78%
Changement Annuel
-93.18%
Clôture Précédente
0.5392
Open
0.5701
Bid
Ask
Low
0.5701
High
0.5840
Volume
22
Open full chart

Financials

Overview Relevé Statistics
Quarterly Annual
  • Market Capitalization 4.7257 M
  • Employee 21
  • Founded N/A
  • CEO N/A
  • Website www.aimimmuno.com
  • Headquarter Delaware, United States
  • FIGI BBG000JL6Z80
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.13
Price to sales ratio
20.76

AIM ImmunoTech Inc

AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome.

Nouvelles